Core Viewpoint - Infolink's recent report highlights that Baijia Niandai has emerged as a "dark horse" in the global photovoltaic (PV) film industry, ranking third with a year-on-year shipment increase of 27% [1][3]. Company Overview - Baijia Niandai, established in 2007 and headquartered in Changzhou, Jiangsu, specializes in the research, production, and sales of functional film materials, including PV encapsulation films and energy storage insulation materials [4][5]. - The company has five production bases in China and Vietnam, with a planned global encapsulation film capacity exceeding 130 GW, and has established long-term strategic partnerships with leading PV companies [5]. Financial Performance - From 2019 to mid-2022, Baijia Niandai's revenue grew from 1 billion to 2 billion yuan, with net profits increasing from 40 million to 190 million yuan, reflecting a strong growth trajectory [5][7]. - In 2024, the company's PV film production is projected to reach approximately 3.8 million square meters [8]. Market Position and Strategy - Previously, the top three positions in the PV film industry were held by Foster, Swick, and Haiyou New Materials, with Baijia Niandai considered a "third-tier" player [3]. - The company is backed by the wealthy Ru family, who control Baixing Group, which spans multiple sectors including industrial manufacturing and real estate [3][9]. - Despite a failed IPO attempt in 2023, Baijia Niandai has accelerated investments in other film companies, recently acquiring a stake in Tianyang New Materials [3][12]. Industry Challenges - The PV film industry is currently facing intense competition, with several leading companies experiencing project delays and cancellations [15]. - Baijia Niandai's rapid growth may be challenged by industry overcapacity and the need for effective integration of acquired assets [15].

Core Viewpoint - Company *ST Lvkang plans to sell its photovoltaic film business assets and liabilities to a newly established entity, Jiangxi Raoxin New Energy Materials Co., Ltd, with a registered capital of RMB 100 million [2][3] Group 1: Transaction Details - The transaction involves the sale of assets and liabilities related to the photovoltaic film business, and after completion, the related subsidiaries will no longer be included in the company's consolidated financial statements [3] - The major shareholder of Jiangxi Raoxin is Shanghai Kangyi Investment Co., Ltd, holding 58.63% of the shares, while other significant shareholders include Hangzhou Yirui Investment Partnership and Hangzhou Haoying Investment Partnership, each holding 16.55% [3] - The transaction will be conducted in cash and will not affect the company's shareholding structure [3] Group 2: Financial Overview - In 2024, the revenue from the photovoltaic film business is projected to be RMB 231 million, representing a year-on-year increase of 60.89%, accounting for 35.62% of total revenue [5] - The gross profit margin for the photovoltaic film business in 2024 is expected to be -38.63, contributing to increased losses for the company [5] - From 2021 to 2024, the company's revenue figures were RMB 363 million, RMB 330 million, RMB 507 million, and RMB 649 million, with net losses totaling RMB 815 million over the four years [5]

Core Viewpoint - *ST Lvkang is facing significant uncertainty regarding its ability to continue operations due to insolvency, while simultaneously engaging in a series of capital actions such as equity transfers that appear to be self-rescue efforts. The question arises whether the company will pursue a backdoor listing or engage in "tri-party transactions" in its capital operations, with the former being potentially more uncertain given the urgency of maintaining its listing status [1] Group 1: Financial Performance and Business Transition - Lvkang Biotech, originally focused on veterinary drug raw materials and probiotics, has seen a decline in performance since its listing in 2017, with a net profit drop of 6.97%, 13.08%, 23.73%, and 24.15% from 2017 to 2020 [2] - In 2021, the company reported a revenue of 363 million yuan, a year-on-year increase of 17.93%, but incurred a net loss of 26.04 million yuan, a decline of 160.28% compared to the previous year [2] - The company entered the photovoltaic film sector in 2022 through acquisitions, leading to a significant stock price increase from around 10 yuan to a peak of 65.9 yuan, representing a more than fivefold increase [2] Group 2: Ongoing Losses and Financial Challenges - Lvkang Biotech has continued to incur losses, with net profits of -122 million yuan, -222 million yuan, and -445 million yuan projected for 2022, 2023, and 2024 respectively, indicating a worsening financial situation [3] - The photovoltaic film business has negatively impacted the company's financial statements due to low gross margins and high financial costs associated with increased bank loans and financing leases [3] - As of December 31, 2024, the company's current liabilities exceeded current assets by over 1 billion yuan, raising significant doubts about its ability to continue as a going concern [4] Group 3: Shareholder Changes and Market Reactions - On April 24, 2025, Lvkang Biotech announced a change in control, with major shareholders transferring shares to Zongteng Network at a price of 13.73 yuan per share, totaling approximately 639.93 million yuan [5] - This transfer will increase Zongteng Network's ownership to 29.99%, surpassing the previous controlling shareholder's stake [5] - The market is speculating whether Zongteng Network's involvement indicates a backdoor listing or a different capital strategy, especially as the company also announced plans to divest its photovoltaic assets [9] Group 4: Strategic Moves and Future Outlook - Lvkang Biotech's recent capital operations, including the divestiture of its photovoltaic film business, may be aimed at clearing obstacles for future transactions [9] - The company signed an asset transfer agreement on April 24, 2025, to sell all assets and liabilities related to its photovoltaic film business to a joint venture established by its shareholders [9] - The potential for a backdoor listing or tri-party transaction remains uncertain, with regulatory hurdles and the urgency of maintaining its listing status complicating the situation [9]

Group 1 - The company reported Q1 2025 revenue of 3.624 billion yuan, a year-on-year decrease of 32%, and a net profit attributable to shareholders of 401 million yuan, down 23% year-on-year [1] - The company's sales volume in the film business is expected to decline both year-on-year and month-on-month in Q1, with a seasonal demand dip in January and February, followed by increased shipments in March due to domestic demand [2] - The company anticipates a recovery in single-watt net profit in Q1, primarily benefiting from price increases in December last year and March this year, maintaining a strong profitability level within the industry [2] Group 2 - The company expects good growth in sales of photosensitive dry film, entering a phase of volume and profit increase as major PCB customers ramp up procurement [3] - For 2025, the company forecasts improved profitability as second- and third-tier companies gradually exit the market, leading to industry consolidation [3] - The company is expanding its overseas film production capacity, initiating the second phase of its Thailand base expansion, which will further increase the proportion of overseas sales [3] Group 3 - The company has established a self-controlled core raw material supply chain and dual manufacturing centers in East and South China, positioning itself for rapid growth in the electronic materials business as the electronic circuit industry recovers [3] - The company's client base includes leading firms in the industry, and its products cater to various manufacturing processes, expanding into packaging substrates to meet high-end chip demands [3] Group 4 - The company is projected to achieve net profits attributable to shareholders of 1.9 billion yuan and 2.6 billion yuan in 2025 and 2026, respectively, corresponding to valuations of 17 and 12 times [4]

Investment Rating - The investment rating for the company is "Buy" and is maintained [6]. Core Views - The company reported a revenue of 2.591 billion yuan for 2024, a year-on-year decrease of 47%, with a net profit attributable to the parent company of -558 million yuan, consistent with preliminary performance reports [2][4]. - In Q4 2024, the company achieved a revenue of 539 million yuan, down 42% year-on-year and 5% quarter-on-quarter, with a net profit of -310 million yuan [2][4]. - For Q1 2025, the company reported a revenue of 316 million yuan, a 64% year-on-year decline and a 41% quarter-on-quarter decline, with a net profit of -57 million yuan [2][4]. - The company is focusing on the automotive business, with positive developments in new products such as PDCLC dimming film, which has been integrated into the Zhiji L6 model, marking a significant technological advancement [10]. - The company is also expanding its overseas market presence, particularly in collaboration with American and Turkish companies, while maintaining a prudent operational strategy in its photovoltaic film business [10]. Financial Summary - The total revenue for 2024 was 2.591 billion yuan, with an operating cost of 2.603 billion yuan, resulting in a gross profit of -11 million yuan [17]. - The company expects to achieve a net operating cash flow of 360 million yuan in 2024, with projections for 2025 indicating a slight increase [17]. - The asset-liability ratio is projected to improve, indicating a reduction in financial risk, with a forecasted asset-liability ratio of 50.2% for 2024 [17].

Investment Rating - The report maintains a "Recommended" rating for the company, indicating an expectation to outperform the benchmark index by 10%-20% over the next six months [20]. Core Insights - The company's revenue for Q1 2025 was 3.624 billion yuan, a year-on-year decrease of 31.89% and a quarter-on-quarter decrease of 8.78%. The net profit attributable to the parent company was 401 million yuan, down 23.08% year-on-year but up 709.79% quarter-on-quarter. The gross margin was 13.10%, a decrease of 2.18 percentage points year-on-year but an increase of 1.48 percentage points quarter-on-quarter [1]. - The company maintains a leading position in the film business, with a market share exceeding 50% in Q1 2025. The gross margin for this segment reached 13.1%, showing a recovery in profitability due to increased demand and price adjustments [7]. - The electronic materials business is expected to see growth, with significant shipments of photosensitive dry film and other products. The company has established relationships with major players in the electronic circuit field, indicating a positive outlook for this segment [7]. - The company has effectively managed credit risks, with a total of 136 million yuan in credit impairment provisions being reversed, contributing positively to the financial performance [7]. Financial Projections - The company is projected to achieve total revenue of 21.297 billion yuan in 2025, with a year-on-year growth rate of 11.2%. The net profit attributable to the parent company is expected to reach 1.680 billion yuan, reflecting a growth rate of 28.5% [3]. - Earnings per share (EPS) are forecasted to increase from 0.50 yuan in 2024 to 0.64 yuan in 2025, with a price-to-earnings (P/E) ratio of 19 times for 2025 [3]. - The target price for the company's stock is set at 16.10 yuan, based on a P/E ratio of 25 times for 2025, compared to the current price of 12.29 yuan [3].

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected price increase of over 15% in the next 6-12 months [5][11]. Core Insights - The company reported Q1 2025 revenue of 3.62 billion yuan, a year-on-year decrease of 32% and a quarter-on-quarter decrease of 9%, with a net profit attributable to shareholders of 401 million yuan, down 23% year-on-year but up 710% quarter-on-quarter, exceeding expectations [2]. - The increase in film prices has led to a recovery in profitability, showcasing the company's leading position in the industry despite challenges. The company shipped 630 million square meters of photovoltaic film in Q1, a 9% year-on-year decline, primarily due to weaker component production. However, price increases in December 2024 and March 2025 have improved the gross margin to 13.10%, a 1.48 percentage point increase quarter-on-quarter [3]. - The company's overseas production capacity is set to expand significantly, with the second phase in Thailand expected to add 250 million square meters, bringing total overseas capacity to 600 million square meters. This expansion is anticipated to enhance profitability and solidify the company's leading position as competitors face losses [3]. - The electronic materials business is experiencing rapid growth, with the introduction of photosensitive dry film products to major global electronic circuit companies. The recovery and transformation of the electronic circuit industry are expected to drive significant growth in this segment [4]. - The company has prudently accounted for credit impairment provisions, which positively impacted net profit by 108 million yuan in Q1 due to a combination of reversals and provisions [4]. Financial Projections - The company's net profit forecasts for 2025-2027 have been adjusted to 1.74 billion, 2.02 billion, and 2.36 billion yuan, respectively. The current stock price corresponds to price-to-earnings ratios of 18, 16, and 13 times for these years, reflecting a strong competitive position and growth potential in the electronic materials sector [5][9].

Core Viewpoint - The company reported significant declines in revenue and net profit for 2024 and Q1 2025, primarily due to pressure on its main film business and substantial asset impairment losses [1][3]. Financial Performance - In 2024, the company achieved revenue of 2.591 billion yuan, a year-on-year decrease of 46.81%, with a net loss attributable to shareholders of 558 million yuan, resulting in a loss per share of 6.65 yuan [1]. - For Q1 2025, revenue was 316 million yuan, down 64.02% year-on-year and 41.37% quarter-on-quarter, with a net loss of 57 million yuan and a loss per share of 0.69 yuan, which was below expectations [1]. Business Trends - The film business faced significant challenges in 2024, with a drastic price drop leading to a sales average of 5.9 yuan per unit, a decrease of 31% year-on-year, and a revenue decline of 48% [1]. - The company opted to abandon low-priced orders, resulting in a decrease in shipment volume and market share, with 2024 sales volume at 420 million square meters, down 25% year-on-year [1]. - Due to falling prices of raw materials and film, some production lines were shut down, leading to a substantial asset impairment loss of 208 million yuan [1]. - The company is implementing a conservative strategy to optimize its asset structure, which has led to a reduction in accounts receivable risk and positive operating cash flow since Q2 2024 [1]. New Business Opportunities - The automotive materials business is expected to become a second growth curve for the company, with 2024 revenue of 20 million yuan, a year-on-year increase of 504.52%, and a gross margin of 28.22% [2]. - The company’s products in this segment include liquid crystal dimming films, XPO leather, and PVE glass glue films, all of which are proprietary technologies [2]. - The recent launch of the Zhiji L6 model, which uses the company's liquid crystal dimming film, indicates market acceptance and potential for further penetration into mid- to low-end models [2]. - The company anticipates batch supply of dimming films and XPO leather products in 2025, with PVE films expected to be promoted in the second half of the year [2]. Profit Forecast and Valuation - Due to low film prices and intense industry competition, the company’s ability to recover profits in the short term is limited, and the automotive materials business is still in its early stages with significant initial R&D and sales expenses [3]. - The net profit forecast for 2025 has been revised down by 286.5% to a loss of 291 million yuan, with an initial 2026 profit forecast of a loss of 65 million yuan [3]. - The target price has been reduced by 18.1% to 45.3 yuan, corresponding to 1.3 and 1.1 times P/S for 2025 and 2026, respectively, indicating a potential upside of 17.6% from the current stock price [3].